Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal Encephalopathy
This study has been completed.
Sponsor:
University Hospital, Toulouse
Information provided by (Responsible Party):
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT01080144
First received: March 2, 2010
Last updated: January 22, 2013
Last verified: January 2013
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | March 2, 2010 | ||||
| Last Updated Date | January 22, 2013 | ||||
| Start Date ICMJE | October 2009 | ||||
| Primary Completion Date | October 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
success rate of Critical Flicker Frequency (CFF) Procedure [ Time Frame: before TIPS and every 3 months till one year ] [ Designated as safety issue: No ] number of patients in whom ten measurement will be available / 30 patients |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01080144 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE |
occurrence of encephalopathy [ Time Frame: every 3 months till one year after TIPS procedure ] [ Designated as safety issue: No ] | ||||
| Original Secondary Outcome Measures ICMJE | Same as current | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Feasibility of Critical Flicker Frequency Procedure for the Diagnosis of Minimal Encephalopathy | ||||
| Official Title ICMJE | A Pilot Study Aiming to Assess the Feasibility of Critical Flicker Frequency for the Diagnosis of Minimal Encephalopathy in Patients With Cirrhosis | ||||
| Brief Summary | All patients eligible for TIPS (Transjugular intrahepatic portosystemic shunt) procedure will be considered for inclusion. After written inform consent, psychometric tests in order to calculate the psychometric hepatic encephalopathy (PHES) score, the gold standard for the diagnosis of minimal encephalopathy and critical flicker frequency (CFF) will be performed before the TIPS procedure. After TIPS, patients will be followed during one year and the psychometric test and CFF will be performed every 3 months. 30 patients will be included. The main endpoint is the success rate of CFF. The secondary end points are
|
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Not Provided | ||||
| Study Design ICMJE | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
||||
| Condition ICMJE | Cirrhosis | ||||
| Intervention ICMJE | Other: Critical flicker frequency procedure
After TIPS, patients will be followed during one year and the psychometric test and Critical flicker frequency procedure will be performed every 3 months |
||||
| Study Arm (s) | Experimental: Critical Flicker Frequency
Critical Flicker Frequency Procedure
Intervention: Other: Critical flicker frequency procedure |
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Completed | ||||
| Enrollment ICMJE | 30 | ||||
| Completion Date | December 2012 | ||||
| Primary Completion Date | October 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Both | ||||
| Ages | 18 Years and older | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects | ||||
| Location Countries ICMJE | France | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01080144 | ||||
| Other Study ID Numbers ICMJE | 09 156 02 | ||||
| Has Data Monitoring Committee | No | ||||
| Responsible Party | University Hospital, Toulouse | ||||
| Study Sponsor ICMJE | University Hospital, Toulouse | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE |
|
||||
| Information Provided By | University Hospital, Toulouse | ||||
| Verification Date | January 2013 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||